The global drug delivery devices market size is expected to reach USD 403.6 billion by 2030, registering a CAGR of 5.83% during the forecast period, according to the report. Growing prevalence of cancer, neurological disorders, diabetes, and other infectious diseases is expected to drive the adoption of drug delivery devices in the coming years. In addition, increasing product launches for various applications such as ophthalmology, neurology, and oncology are also expected to propel the market growth. Growing adoption of wearable drug delivery devices for its usage in home-care settings is also expected to drive the market. ![Global Drug Delivery Devices Market]( "Global Drug Delivery Devices Market")
Hydrogel is one of the prominent drug delivery vehicles and includes supramolecular hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and stimuli-responsive hydrogels. These advanced hydrogels are used for various applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer. Similarly, other vehicles such as liposomes, nanoparticles, and micelle are also being developed for various applications.
Key players present in the market are adopting various strategies such as mergers and acquisitions, partnership, and collaborations to develop and improve drug delivery devices for various applications. Moreover, end-users are also forming partnerships with companies to acquire drug delivery devices for training purpose and research studies. In addition, market players are also forming distribution agreement to expand the reach of their products. Therefore, alliances made by the players are expected to drive the market growth during the forecast period.
Hydrogel is one of the prominent drug delivery vehicles and includes supramolecular hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and stimuli-responsive hydrogels. These advanced hydrogels are used for various applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer. Similarly, other vehicles such as liposomes, nanoparticles, and micelle are also being developed for various applications.
Key players present in the market are adopting various strategies such as mergers and acquisitions, partnership, and collaborations to develop and improve drug delivery devices for various applications. Moreover, end-users are also forming partnerships with companies to acquire drug delivery devices for training purpose and research studies. In addition, market players are also forming distribution agreement to expand the reach of their products. Therefore, alliances made by the players are expected to drive the market growth during the forecast period.
Drug Delivery Devices Market Report Highlights
- The oral route of administration segment held largest share in 2023 mainly due to its easy usage and low cost
- The injectable route of administration segment is expected to experience the fastest growth during the forecast period mainly due to growing advancements in injectable devices for accuracy
- Drug delivery devices for central nervous system disorders are expected to experience fastest growth rate mainly due to growing development of blood brain barrier drug delivery devices for the treatment of neurological disorders
- In 2023, North America dominated the global space with the largest revenue share owing to the adoption of drug delivery devices in the region and increasing product launches in the countries such as U.S.
- Asia Pacific is expected to grow at fastest growth rate during the forecast period mainly due to growing development and advancement in drug delivery devices in the region and presence of large patient pool.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Route of admission (RoA)
1.1.2. Application
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interview in North America
1.3.5.2. Data for primary interview in Europe
1.3.5.3. Data for primary interview in Asia Pacific
1.3.5.4. Data for primary interview in Latin America
1.3.5.5. Data for primary interview in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.1.1. Route of admission (RoA)
1.1.2. Application
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interview in North America
1.3.5.2. Data for primary interview in Europe
1.3.5.3. Data for primary interview in Asia Pacific
1.3.5.4. Data for primary interview in Latin America
1.3.5.5. Data for primary interview in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Route of administration (RoA) outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Route of administration (RoA) outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Growing demand for novel drug delivery devices
3.4.1.2. Increasing prevalence of chronic diseases
3.4.1.3. Technological advancement in drug delivery devices
3.4.1.4. Growing strategic alliances for drug delivery devices
3.4.2. Market restraint analysis
3.4.2.1. Challenges associated with various routes of drug delivery devices
3.4.3. Industry challenges
3.5. Drug Delivery Devices Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Growing demand for novel drug delivery devices
3.4.1.2. Increasing prevalence of chronic diseases
3.4.1.3. Technological advancement in drug delivery devices
3.4.1.4. Growing strategic alliances for drug delivery devices
3.4.2. Market restraint analysis
3.4.2.1. Challenges associated with various routes of drug delivery devices
3.4.3. Industry challenges
3.5. Drug Delivery Devices Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Route of Administration (RoA) Estimates & Trend Analysis
4.1. Definition and Scope
4.1.1. Oral
4.1.2. Inhalation
4.1.3. Transdermal
4.1.4. Injectable
4.1.5. Ocular
4.1.6. Nasal
4.1.7. Topical
4.1.8. Others
4.2. RoA Market Share, 2024 & 2030
4.3. Segment Dashboard
4.4. Global Drug Delivery Devices Market by RoA Outlook
4.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
4.5.1. Oral
4.5.1.1. Market estimates and forecast, by oral, 2018 to 2030 (Revenue, USD Billion)
4.5.2. Inhalation
4.5.2.1. Market estimates and forecast, by inhalation, 2018 to 2030 (Revenue, USD Billion)
4.5.3. Transdermal
4.5.3.1. Market estimates and forecast, by transdermal, 2018 to 2030 (Revenue, USD Billion)
4.5.4. Injectable
4.5.4.1. Market estimates and forecast, by injectable, 2018 to 2030 (Revenue, USD Billion)
4.5.5. Ocular
4.5.5.1. Market estimates and forecast, by ocular, 2018 to 2030 (Revenue, USD Billion)
4.5.6. Nasal
4.5.6.1. Market estimates and forecast, by nasal, 2018 to 2030 (Revenue, USD Billion)
4.5.7. Topical
4.5.7.1. Market estimates and forecast, by tropical, 2018 to 2030 (Revenue, USD Billion)
4.5.8. Others
4.5.8.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)
4.1.1. Oral
4.1.2. Inhalation
4.1.3. Transdermal
4.1.4. Injectable
4.1.5. Ocular
4.1.6. Nasal
4.1.7. Topical
4.1.8. Others
4.2. RoA Market Share, 2024 & 2030
4.3. Segment Dashboard
4.4. Global Drug Delivery Devices Market by RoA Outlook
4.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
4.5.1. Oral
4.5.1.1. Market estimates and forecast, by oral, 2018 to 2030 (Revenue, USD Billion)
4.5.2. Inhalation
4.5.2.1. Market estimates and forecast, by inhalation, 2018 to 2030 (Revenue, USD Billion)
4.5.3. Transdermal
4.5.3.1. Market estimates and forecast, by transdermal, 2018 to 2030 (Revenue, USD Billion)
4.5.4. Injectable
4.5.4.1. Market estimates and forecast, by injectable, 2018 to 2030 (Revenue, USD Billion)
4.5.5. Ocular
4.5.5.1. Market estimates and forecast, by ocular, 2018 to 2030 (Revenue, USD Billion)
4.5.6. Nasal
4.5.6.1. Market estimates and forecast, by nasal, 2018 to 2030 (Revenue, USD Billion)
4.5.7. Topical
4.5.7.1. Market estimates and forecast, by tropical, 2018 to 2030 (Revenue, USD Billion)
4.5.8. Others
4.5.8.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)
Chapter 5. Application Estimates & Trend Analysis
5.1. Definition and Scope
5.1.1. Oncology
5.1.2. Infectious diseases
5.1.3. Respiratory disease
5.1.4. Diabetes
5.1.5. Cardiovascular disease
5.1.6. Autoimmune disease
5.1.7. Central nervous system disorders
5.1.8. Others
5.2. Application Market Share, 2024 & 2030
5.3. Segment Dashboard
5.4. Global Drug Delivery Devices Market by Application Outlook
5.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
5.5.1. Oncology
5.5.1.1. Market estimates and forecast, by oncology, 2018 to 2030 (Revenue, USD Billion)
5.5.2. Infectious disease
5.5.2.1. Market estimates and forecast, by infectious disease, 2018 to 2030 (Revenue, USD Billion)
5.5.3. Respiratory disease
5.5.3.1. Market estimates and forecast, by respiratory disease, 2018 to 2030 (Revenue, USD Billion)
5.5.4. Diabetes
5.5.4.1. Market estimates and forecast, by diabetes, 2018 to 2030 (Revenue, USD Billion)
5.5.5. Cardiovascular diseases
5.5.5.1. Market estimates and forecast, by cardiovascular diseases, 2018 to 2030 (Revenue, USD Billion)
5.5.6. Autoimmune disease
5.5.6.1. Market estimates and forecast, by autoimmune disease, 2018 to 2030 (Revenue, USD Billion)
5.5.7. Central nervous system disorders
5.5.7.1. Market estimates and forecast, by central nervous system disorders, 2018 to 2030 (Revenue, USD Billion)
5.5.8. Others
5.5.8.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)
5.1.1. Oncology
5.1.2. Infectious diseases
5.1.3. Respiratory disease
5.1.4. Diabetes
5.1.5. Cardiovascular disease
5.1.6. Autoimmune disease
5.1.7. Central nervous system disorders
5.1.8. Others
5.2. Application Market Share, 2024 & 2030
5.3. Segment Dashboard
5.4. Global Drug Delivery Devices Market by Application Outlook
5.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
5.5.1. Oncology
5.5.1.1. Market estimates and forecast, by oncology, 2018 to 2030 (Revenue, USD Billion)
5.5.2. Infectious disease
5.5.2.1. Market estimates and forecast, by infectious disease, 2018 to 2030 (Revenue, USD Billion)
5.5.3. Respiratory disease
5.5.3.1. Market estimates and forecast, by respiratory disease, 2018 to 2030 (Revenue, USD Billion)
5.5.4. Diabetes
5.5.4.1. Market estimates and forecast, by diabetes, 2018 to 2030 (Revenue, USD Billion)
5.5.5. Cardiovascular diseases
5.5.5.1. Market estimates and forecast, by cardiovascular diseases, 2018 to 2030 (Revenue, USD Billion)
5.5.6. Autoimmune disease
5.5.6.1. Market estimates and forecast, by autoimmune disease, 2018 to 2030 (Revenue, USD Billion)
5.5.7. Central nervous system disorders
5.5.7.1. Market estimates and forecast, by central nervous system disorders, 2018 to 2030 (Revenue, USD Billion)
5.5.8. Others
5.5.8.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)
Chapter 6. End-use Estimates & Trend Analysis
6.1. Definition and Scope
6.1.1. Hospitals
6.1.2. Diagnostic centers
6.1.3. Ambulatory surgery centers/clinics
6.1.4. Home care settings
6.1.5. Others
6.2. End-use Market Share, 2023 & 2030
6.3. Segment Dashboard
6.4. Global Drug Delivery Devices Market by End-use Outlook
6.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
6.5.1. Hospital
6.5.1.1. Market estimates and forecast, by hospital, 2018 to 2030 (Revenue, USD Billion)
6.5.2. Diagnostic centers
6.5.2.1. Market estimates and forecast, by diagnostic centers, 2018 to 2030 (Revenue, USD Billion)
6.5.3. Ambulatory surgery centers/clinics
6.5.3.1. Market estimates and forecast, by ambulatory surgery centers/clinics, 2018 to 2030 (Revenue, USD Billion)
6.5.4. Home care settings
6.5.4.1. Market estimates and forecast, by home care settings, 2018 to 2030 (Revenue, USD Billion)
6.5.5. Others
6.5.5.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)
6.1.1. Hospitals
6.1.2. Diagnostic centers
6.1.3. Ambulatory surgery centers/clinics
6.1.4. Home care settings
6.1.5. Others
6.2. End-use Market Share, 2023 & 2030
6.3. Segment Dashboard
6.4. Global Drug Delivery Devices Market by End-use Outlook
6.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
6.5.1. Hospital
6.5.1.1. Market estimates and forecast, by hospital, 2018 to 2030 (Revenue, USD Billion)
6.5.2. Diagnostic centers
6.5.2.1. Market estimates and forecast, by diagnostic centers, 2018 to 2030 (Revenue, USD Billion)
6.5.3. Ambulatory surgery centers/clinics
6.5.3.1. Market estimates and forecast, by ambulatory surgery centers/clinics, 2018 to 2030 (Revenue, USD Billion)
6.5.4. Home care settings
6.5.4.1. Market estimates and forecast, by home care settings, 2018 to 2030 (Revenue, USD Billion)
6.5.5. Others
6.5.5.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)
Chapter 7. Drug Delivery Devices Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2019
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East & Africa
7.5. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East & Africa
7.6. Market Size & Forecast, Volume & Trend Analysis, 2018 to 2030
7.7. North America
7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.2. U.S.
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement structure
7.7.2.5. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.7.3. Canada
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement structure
7.7.3.5. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8. Europe
7.8.1. UK
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement structure
7.8.1.5. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8.2. Germany
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement structure
7.8.2.5. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8.3. France
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Regulatory framework
7.8.3.4. Reimbursement structure
7.8.3.5. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8.4. Italy
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. Regulatory framework
7.8.4.4. Reimbursement structure
7.8.4.5. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8.5. Spain
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Regulatory framework
7.8.5.4. Reimbursement structure
7.8.5.5. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8.6. Denmark
7.8.6.1. Key country dynamics
7.8.6.2. Competitive scenario
7.8.6.3. Regulatory framework
7.8.6.4. Reimbursement structure
7.8.6.5. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8.7. Sweden
7.8.7.1. Key country dynamics
7.8.7.2. Competitive scenario
7.8.7.3. Regulatory framework
7.8.7.4. Reimbursement structure
7.8.7.5. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8.8. Norway
7.8.8.1. Key country dynamics
7.8.8.2. Competitive scenario
7.8.8.3. Regulatory framework
7.8.8.4. Reimbursement structure
7.8.8.5. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.9. Asia Pacific
7.9.1. Japan
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement structure
7.9.1.5. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.9.2. China
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement structure
7.9.2.5. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.9.3. India
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement structure
7.9.3.5. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.9.4. Australia
7.9.4.1. Key country dynamics
7.9.4.2. Competitive scenario
7.9.4.3. Regulatory framework
7.9.4.4. Reimbursement structure
7.9.4.5. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.9.5. South Korea
7.9.5.1. Key country dynamics
7.9.5.2. Competitive scenario
7.9.5.3. Regulatory framework
7.9.5.4. Reimbursement structure
7.9.5.5. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.9.6. Thailand
7.9.6.1. Key country dynamics
7.9.6.2. Competitive scenario
7.9.6.3. Regulatory framework
7.9.6.4. Reimbursement structure
7.9.6.5. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Key country dynamics
7.10.1.2. Competitive scenario
7.10.1.3. Regulatory framework
7.10.1.4. Reimbursement structure
7.10.1.5. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.10.2. Mexico
7.10.2.1. Key country dynamics
7.10.2.2. Competitive scenario
7.10.2.3. Regulatory framework
7.10.2.4. Reimbursement structure
7.10.2.5. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.10.3. Argentina
7.10.3.1. Key country dynamics
7.10.3.2. Competitive scenario
7.10.3.3. Regulatory framework
7.10.3.4. Reimbursement structure
7.10.3.5. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.11. MEA
7.11.1. South Africa
7.11.1.1. Key country dynamics
7.11.1.2. Competitive scenario
7.11.1.3. Regulatory framework
7.11.1.4. Reimbursement structure
7.11.1.5. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.11.2. Saudi Arabia
7.11.2.1. Key country dynamics
7.11.2.2. Competitive scenario
7.11.2.3. Regulatory framework
7.11.2.4. Reimbursement structure
7.11.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.11.3. UAE
7.11.3.1. Key country dynamics
7.11.3.2. Competitive scenario
7.11.3.3. Regulatory framework
7.11.3.4. Reimbursement structure
7.11.3.5. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.11.4. Kuwait
7.11.4.1. Key country dynamics
7.11.4.2. Competitive scenario
7.11.4.3. Regulatory framework
7.11.4.4. Reimbursement structure
7.11.4.5. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2019
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East & Africa
7.5. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East & Africa
7.6. Market Size & Forecast, Volume & Trend Analysis, 2018 to 2030
7.7. North America
7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.2. U.S.
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement structure
7.7.2.5. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.7.3. Canada
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement structure
7.7.3.5. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8. Europe
7.8.1. UK
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement structure
7.8.1.5. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8.2. Germany
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement structure
7.8.2.5. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8.3. France
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Regulatory framework
7.8.3.4. Reimbursement structure
7.8.3.5. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8.4. Italy
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. Regulatory framework
7.8.4.4. Reimbursement structure
7.8.4.5. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8.5. Spain
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Regulatory framework
7.8.5.4. Reimbursement structure
7.8.5.5. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8.6. Denmark
7.8.6.1. Key country dynamics
7.8.6.2. Competitive scenario
7.8.6.3. Regulatory framework
7.8.6.4. Reimbursement structure
7.8.6.5. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8.7. Sweden
7.8.7.1. Key country dynamics
7.8.7.2. Competitive scenario
7.8.7.3. Regulatory framework
7.8.7.4. Reimbursement structure
7.8.7.5. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.8.8. Norway
7.8.8.1. Key country dynamics
7.8.8.2. Competitive scenario
7.8.8.3. Regulatory framework
7.8.8.4. Reimbursement structure
7.8.8.5. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.9. Asia Pacific
7.9.1. Japan
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement structure
7.9.1.5. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.9.2. China
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement structure
7.9.2.5. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.9.3. India
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement structure
7.9.3.5. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.9.4. Australia
7.9.4.1. Key country dynamics
7.9.4.2. Competitive scenario
7.9.4.3. Regulatory framework
7.9.4.4. Reimbursement structure
7.9.4.5. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.9.5. South Korea
7.9.5.1. Key country dynamics
7.9.5.2. Competitive scenario
7.9.5.3. Regulatory framework
7.9.5.4. Reimbursement structure
7.9.5.5. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.9.6. Thailand
7.9.6.1. Key country dynamics
7.9.6.2. Competitive scenario
7.9.6.3. Regulatory framework
7.9.6.4. Reimbursement structure
7.9.6.5. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Key country dynamics
7.10.1.2. Competitive scenario
7.10.1.3. Regulatory framework
7.10.1.4. Reimbursement structure
7.10.1.5. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.10.2. Mexico
7.10.2.1. Key country dynamics
7.10.2.2. Competitive scenario
7.10.2.3. Regulatory framework
7.10.2.4. Reimbursement structure
7.10.2.5. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.10.3. Argentina
7.10.3.1. Key country dynamics
7.10.3.2. Competitive scenario
7.10.3.3. Regulatory framework
7.10.3.4. Reimbursement structure
7.10.3.5. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.11. MEA
7.11.1. South Africa
7.11.1.1. Key country dynamics
7.11.1.2. Competitive scenario
7.11.1.3. Regulatory framework
7.11.1.4. Reimbursement structure
7.11.1.5. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.11.2. Saudi Arabia
7.11.2.1. Key country dynamics
7.11.2.2. Competitive scenario
7.11.2.3. Regulatory framework
7.11.2.4. Reimbursement structure
7.11.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.11.3. UAE
7.11.3.1. Key country dynamics
7.11.3.2. Competitive scenario
7.11.3.3. Regulatory framework
7.11.3.4. Reimbursement structure
7.11.3.5. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
7.11.4. Kuwait
7.11.4.1. Key country dynamics
7.11.4.2. Competitive scenario
7.11.4.3. Regulatory framework
7.11.4.4. Reimbursement structure
7.11.4.5. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.2.2. Market Lenders
8.2.3. Emerging Players
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.4. Public Companies
8.4.1. Company market position analysis (Revenue, geographic, presence, product portfolio, key serviceable industries, key alliance
8.4.2. Company market share/ranking, by region
8.4.3. Competitive dashboard analysis
8.4.3.1. Market differentiators
8.4.3.2. Synergy analysis: major deals and strategic alliances
8.5. Private Companies
8.5.1. List of key emerging companies/technology disruptors/innovators
8.5.2. Funding outlook
8.5.3. Regional network map
8.5.4. Company market position analysis (Geographic, presence, product portfolio, key alliance, industry experience)
8.6. Suppliers Ranking
8.7. Key Companies Profiled
8.7.1. Pfizer, Inc,
8.7.1.1. Company overview
8.7.1.2. Financial performance
8.7.1.3. Product benchmarking
8.7.1.4. Strategic initiatives
8.7.2. F. Hoffmann-La Roche Ltd.
8.7.2.1. Company overview
8.7.2.2. Financial performance
8.7.2.3. Product benchmarking
8.7.2.4. Strategic initiatives
8.7.3. Johnson and Johnson Services
8.7.3.1. Company overview
8.7.3.2. Financial performance
8.7.3.3. Product benchmarking
8.7.3.4. Strategic initiatives
8.7.4. Novartis AG
8.7.4.1. Company overview
8.7.4.2. Financial performance
8.7.4.3. Product benchmarking
8.7.4.4. Strategic initiatives
8.7.5. Bayer AG
8.7.5.1. Company overview
8.7.5.2. Financial performance
8.7.5.3. Product benchmarking
8.7.5.4. Strategic initiatives
8.7.6. BD
8.7.6.1. Company overview
8.7.6.2. Financial performance
8.7.6.3. Product benchmarking
8.7.6.4. Strategic initiatives
8.7.7. Uniqure N.V.
8.7.7.1. Company overview
8.7.7.2. Financial performance
8.7.7.3. Product benchmarking
8.7.7.4. Strategic initiatives
8.7.8. SiBiono GeneTech Co.
8.7.8.1. Company overview
8.7.8.2. Financial performance
8.7.8.3. Product benchmarking
8.7.8.4. Strategic initiatives
8.7.9. Shanghai Sunway Biotech Co., Ltd
8.7.9.1. Company overview
8.7.9.2. Financial performance
8.7.9.3. Product benchmarking
8.7.9.4. Strategic initiatives
8.7.10. Human Stem Cells Institute
8.7.10.1. Company overview
8.7.10.2. Financial performance
8.7.10.3. Product benchmarking
8.7.10.4. Strategic initiatives
8.2. Company/Competition Categorization
8.2.1. Innovators
8.2.2. Market Lenders
8.2.3. Emerging Players
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.4. Public Companies
8.4.1. Company market position analysis (Revenue, geographic, presence, product portfolio, key serviceable industries, key alliance
8.4.2. Company market share/ranking, by region
8.4.3. Competitive dashboard analysis
8.4.3.1. Market differentiators
8.4.3.2. Synergy analysis: major deals and strategic alliances
8.5. Private Companies
8.5.1. List of key emerging companies/technology disruptors/innovators
8.5.2. Funding outlook
8.5.3. Regional network map
8.5.4. Company market position analysis (Geographic, presence, product portfolio, key alliance, industry experience)
8.6. Suppliers Ranking
8.7. Key Companies Profiled
8.7.1. Pfizer, Inc,
8.7.1.1. Company overview
8.7.1.2. Financial performance
8.7.1.3. Product benchmarking
8.7.1.4. Strategic initiatives
8.7.2. F. Hoffmann-La Roche Ltd.
8.7.2.1. Company overview
8.7.2.2. Financial performance
8.7.2.3. Product benchmarking
8.7.2.4. Strategic initiatives
8.7.3. Johnson and Johnson Services
8.7.3.1. Company overview
8.7.3.2. Financial performance
8.7.3.3. Product benchmarking
8.7.3.4. Strategic initiatives
8.7.4. Novartis AG
8.7.4.1. Company overview
8.7.4.2. Financial performance
8.7.4.3. Product benchmarking
8.7.4.4. Strategic initiatives
8.7.5. Bayer AG
8.7.5.1. Company overview
8.7.5.2. Financial performance
8.7.5.3. Product benchmarking
8.7.5.4. Strategic initiatives
8.7.6. BD
8.7.6.1. Company overview
8.7.6.2. Financial performance
8.7.6.3. Product benchmarking
8.7.6.4. Strategic initiatives
8.7.7. Uniqure N.V.
8.7.7.1. Company overview
8.7.7.2. Financial performance
8.7.7.3. Product benchmarking
8.7.7.4. Strategic initiatives
8.7.8. SiBiono GeneTech Co.
8.7.8.1. Company overview
8.7.8.2. Financial performance
8.7.8.3. Product benchmarking
8.7.8.4. Strategic initiatives
8.7.9. Shanghai Sunway Biotech Co., Ltd
8.7.9.1. Company overview
8.7.9.2. Financial performance
8.7.9.3. Product benchmarking
8.7.9.4. Strategic initiatives
8.7.10. Human Stem Cells Institute
8.7.10.1. Company overview
8.7.10.2. Financial performance
8.7.10.3. Product benchmarking
8.7.10.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America drug delivery devices market, by country, 2018 - 2030 (USD Billion)
Table 3 North America drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 4 North America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 5 North America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 6 U.S. drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 7 U.S. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 8 U.S. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 9 Canada drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 10 Canada drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 11 Canada drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 12 Europe drug delivery devices market, by region, 2018 - 2030 (USD Billion)
Table 13 Europe drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 14 Europe drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 15 Europe drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 16 Germany drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 17 Germany drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 18 Germany drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 19 U.K. drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 20 U.K. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 21 U.K. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 22 France drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 23 France drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 24 France drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 25 Italy drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 26 Italy drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 27 Italy drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 28 Spain drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 29 Spain drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 30 Spain drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 31 Denmark drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 32 Denmark drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 33 Denmark drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 34 Sweden drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 35 Sweden drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 36 Sweden drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 37 Norway drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 38 Norway drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 39 Norway drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 40 APAC drug delivery devices market, by region, 2018 - 2030 (USD Billion)
Table 41 APAC drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 42 APAC drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 43 APAC drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 44 China drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 45 China drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 46 China drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 47 Japan drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 48 Japan drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 49 Japan drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 50 India drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 51 India drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 52 India drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 53 Thailand drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 54 Thailand drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 55 Thailand drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 56 South Korea drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 57 South Korea drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 58 South Korea drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 59 Australia drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 60 Australia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 61 Australia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 62 Latin America drug delivery devices market, by region, 2018 - 2030 (USD Billion)
Table 63 Latin America drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 64 Latin America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 65 Latin America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 66 Brazil drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 67 Brazil drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 68 Brazil drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 69 Mexico drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 70 Mexico drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 71 Mexico drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 72 Argentina drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 73 Argentina drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 74 Argentina drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 75 Middle East and Africa drug delivery devices market, by region, 2018 - 2030 (USD Billion)
Table 76 Middle East and Africa drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 77 Middle East and Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 78 Middle East and Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 79 South Africa drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 80 South Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 81 South Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 82 Saudi Arabia drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 83 Saudi Arabia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 84 Saudi Arabia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 85 UAE drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 86 UAE drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 87 UAE drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 88 Kuwait drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 89 Kuwait drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 90 Kuwait drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 2 North America drug delivery devices market, by country, 2018 - 2030 (USD Billion)
Table 3 North America drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 4 North America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 5 North America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 6 U.S. drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 7 U.S. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 8 U.S. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 9 Canada drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 10 Canada drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 11 Canada drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 12 Europe drug delivery devices market, by region, 2018 - 2030 (USD Billion)
Table 13 Europe drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 14 Europe drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 15 Europe drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 16 Germany drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 17 Germany drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 18 Germany drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 19 U.K. drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 20 U.K. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 21 U.K. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 22 France drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 23 France drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 24 France drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 25 Italy drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 26 Italy drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 27 Italy drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 28 Spain drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 29 Spain drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 30 Spain drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 31 Denmark drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 32 Denmark drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 33 Denmark drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 34 Sweden drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 35 Sweden drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 36 Sweden drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 37 Norway drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 38 Norway drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 39 Norway drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 40 APAC drug delivery devices market, by region, 2018 - 2030 (USD Billion)
Table 41 APAC drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 42 APAC drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 43 APAC drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 44 China drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 45 China drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 46 China drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 47 Japan drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 48 Japan drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 49 Japan drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 50 India drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 51 India drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 52 India drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 53 Thailand drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 54 Thailand drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 55 Thailand drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 56 South Korea drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 57 South Korea drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 58 South Korea drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 59 Australia drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 60 Australia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 61 Australia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 62 Latin America drug delivery devices market, by region, 2018 - 2030 (USD Billion)
Table 63 Latin America drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 64 Latin America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 65 Latin America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 66 Brazil drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 67 Brazil drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 68 Brazil drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 69 Mexico drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 70 Mexico drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 71 Mexico drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 72 Argentina drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 73 Argentina drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 74 Argentina drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 75 Middle East and Africa drug delivery devices market, by region, 2018 - 2030 (USD Billion)
Table 76 Middle East and Africa drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 77 Middle East and Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 78 Middle East and Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 79 South Africa drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 80 South Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 81 South Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 82 Saudi Arabia drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 83 Saudi Arabia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 84 Saudi Arabia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 85 UAE drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 86 UAE drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 87 UAE drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
Table 88 Kuwait drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
Table 89 Kuwait drug delivery devices market, by application, 2018 - 2030 (USD Billion)
Table 90 Kuwait drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Drug delivery devices: market outlook
Fig. 14 Drug delivery devices market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook.
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Drug delivery devices market driver impact
Fig. 20 Drug delivery devices market restraint impact
Fig. 21 Drug delivery devices market strategic initiatives analysis
Fig. 22 Drug delivery devices market: RoA movement analysis
Fig. 23 Drug delivery devices market: RoA outlook and key takeaways
Fig. 24 Oral market estimates and forecast, 2018 - 2030
Fig. 25 Inhalation market estimates and forecast, 2018 - 2030
Fig. 26 Transdermal market estimates and forecast, 2018 - 2030
Fig. 27 Injectable market estimates and forecast, 2018 - 2030
Fig. 28 Ocular market estimates and forecast, 2018 - 2030
Fig. 29 Nasal market estimates and forecast, 2018 - 2030
Fig. 30 Topical market estimates and forecast, 2018 - 2030
Fig. 31 Others market estimates and forecast, 2018 - 2030
Fig. 32 Drug delivery devices market: application movement analysis
Fig. 33 Drug delivery devices market: application outlook and key takeaways
Fig. 34 Oncology market estimates and forecast, 2018 - 2030
Fig. 35 Infectious diseases estimates and forecast, 2018 - 2030
Fig. 36 Respiratory diseases estimates and forecast, 2018 - 2030
Fig. 37 Diabetes estimates and forecast, 2018 - 2030
Fig. 38 Cardiovascular diseases estimates and forecast, 2018 - 2030
Fig. 39 Autoimmune diseases estimates and forecast, 2018 - 2030
Fig. 40 Central nervous system disorders estimates and forecast, 2018 - 2030
Fig. 41 Others estimates and forecast, 2018 - 2030
Fig. 42 Drug delivery devices market: end-use movement analysis
Fig. 43 Drug delivery devices market: End-use outlook and key takeaways
Fig. 44 Hospitals estimates and forecast, 2018 - 2030
Fig. 45 Diagnostic centers estimates and forecast, 2018 - 2030
Fig. 46 Ambulatory surgery centers/clinics estimates and forecast, 2018 - 2030
Fig. 47 Home care setting estimates and forecast, 2018 - 2030
Fig. 48 Others estimates and forecast, 2018 - 2030
Fig. 49 Global drug delivery devices market: regional movement analysis
Fig. 50 Global drug delivery market: regional outlook and key takeaways
Fig. 51 Global market share and leading players
Fig. 52 North America market share and leading players
Fig. 53 Europe market share and leading players
Fig. 54 Asia Pacific market share and leading players
Fig. 55 Latin America market share and leading players
Fig. 56 Middle East & Africa market share and leading players
Fig. 57 North America: SWOT
Fig. 58 Europe SWOT
Fig. 59 Asia Pacific SWOT
Fig. 60 Latin America SWOT
Fig. 61 MEA SWOT
Fig. 62 North America, by country
Fig. 63 North America
Fig. 64 North America market estimates and forecast, 2018 - 2030
Fig. 65 U.S.
Fig. 66 U.S. market estimates and forecast, 2018 - 2030
Fig. 67 Canada
Fig. 68 Canada market estimates and forecast, 2018 - 2030
Fig. 69 Europe
Fig. 70 Europe. market estimates and forecast, 2018 - 2030
Fig. 71 UK
Fig. 72 UK market estimates and forecast, 2018 - 2030
Fig. 73 Germany
Fig. 74 Germany market estimates and forecast, 2018 - 2030
Fig. 75 France
Fig. 76 France market estimates and forecast, 2018 - 2030
Fig. 77 Italy
Fig. 78 Italy market estimates and forecast, 2018 - 2030
Fig. 79 Spain
Fig. 80 Spain market estimates and forecast, 2018 - 2030
Fig. 81 Denmark
Fig. 82 Denmark market estimates and forecast, 2018 - 2030
Fig. 83 Sweden
Fig. 84 Sweden market estimates and forecast, 2018 - 2030
Fig. 85 Norway
Fig. 86 Norway market estimates and forecast, 2018 - 2030
Fig. 87 Asia Pacific
Fig. 88 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 89 China
Fig. 90 China market estimates and forecast, 2018 - 2030
Fig. 91 Japan
Fig. 92 Japan market estimates and forecast, 2018 - 2030
Fig. 93 India
Fig. 94 India market estimates and forecast, 2018 - 2030
Fig. 95 Thailand
Fig. 96 Thailand. market estimates and forecast, 2018 - 2030
Fig. 97 South Korea
Fig. 98 South Korea market estimates and forecast, 2018 - 2030
Fig. 99 Australia
Fig. 100 Australia market estimates and forecast, 2018 - 2030
Fig. 101 Latin America
Fig. 102 Latin America market estimates and forecast, 2018 - 2030
Fig. 103 Brazil
Fig. 104 Brazil market estimates and forecast, 2018 - 2030
Fig. 105 Mexico
Fig. 106 Mexico market estimates and forecast, 2018 - 2030
Fig. 107 Argentina
Fig. 108 Argentina market estimates and forecast, 2018 - 2030
Fig. 109 Middle East and Africa
Fig. 110 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 111 South Africa
Fig. 112 South Africa market estimates and forecast, 2018 - 2030
Fig. 113 Saudi Arabia
Fig. 114 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 115 UAE
Fig. 116 UAE market estimates and forecast, 2018 - 2030
Fig. 117 Kuwait
Fig. 118 Kuwait market estimates and forecast, 2018 - 2030
Fig. 119 Participant categorization- drug delivery devices market
Fig. 120 Market share of key market players- drug delivery devices market
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Drug delivery devices: market outlook
Fig. 14 Drug delivery devices market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook.
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Drug delivery devices market driver impact
Fig. 20 Drug delivery devices market restraint impact
Fig. 21 Drug delivery devices market strategic initiatives analysis
Fig. 22 Drug delivery devices market: RoA movement analysis
Fig. 23 Drug delivery devices market: RoA outlook and key takeaways
Fig. 24 Oral market estimates and forecast, 2018 - 2030
Fig. 25 Inhalation market estimates and forecast, 2018 - 2030
Fig. 26 Transdermal market estimates and forecast, 2018 - 2030
Fig. 27 Injectable market estimates and forecast, 2018 - 2030
Fig. 28 Ocular market estimates and forecast, 2018 - 2030
Fig. 29 Nasal market estimates and forecast, 2018 - 2030
Fig. 30 Topical market estimates and forecast, 2018 - 2030
Fig. 31 Others market estimates and forecast, 2018 - 2030
Fig. 32 Drug delivery devices market: application movement analysis
Fig. 33 Drug delivery devices market: application outlook and key takeaways
Fig. 34 Oncology market estimates and forecast, 2018 - 2030
Fig. 35 Infectious diseases estimates and forecast, 2018 - 2030
Fig. 36 Respiratory diseases estimates and forecast, 2018 - 2030
Fig. 37 Diabetes estimates and forecast, 2018 - 2030
Fig. 38 Cardiovascular diseases estimates and forecast, 2018 - 2030
Fig. 39 Autoimmune diseases estimates and forecast, 2018 - 2030
Fig. 40 Central nervous system disorders estimates and forecast, 2018 - 2030
Fig. 41 Others estimates and forecast, 2018 - 2030
Fig. 42 Drug delivery devices market: end-use movement analysis
Fig. 43 Drug delivery devices market: End-use outlook and key takeaways
Fig. 44 Hospitals estimates and forecast, 2018 - 2030
Fig. 45 Diagnostic centers estimates and forecast, 2018 - 2030
Fig. 46 Ambulatory surgery centers/clinics estimates and forecast, 2018 - 2030
Fig. 47 Home care setting estimates and forecast, 2018 - 2030
Fig. 48 Others estimates and forecast, 2018 - 2030
Fig. 49 Global drug delivery devices market: regional movement analysis
Fig. 50 Global drug delivery market: regional outlook and key takeaways
Fig. 51 Global market share and leading players
Fig. 52 North America market share and leading players
Fig. 53 Europe market share and leading players
Fig. 54 Asia Pacific market share and leading players
Fig. 55 Latin America market share and leading players
Fig. 56 Middle East & Africa market share and leading players
Fig. 57 North America: SWOT
Fig. 58 Europe SWOT
Fig. 59 Asia Pacific SWOT
Fig. 60 Latin America SWOT
Fig. 61 MEA SWOT
Fig. 62 North America, by country
Fig. 63 North America
Fig. 64 North America market estimates and forecast, 2018 - 2030
Fig. 65 U.S.
Fig. 66 U.S. market estimates and forecast, 2018 - 2030
Fig. 67 Canada
Fig. 68 Canada market estimates and forecast, 2018 - 2030
Fig. 69 Europe
Fig. 70 Europe. market estimates and forecast, 2018 - 2030
Fig. 71 UK
Fig. 72 UK market estimates and forecast, 2018 - 2030
Fig. 73 Germany
Fig. 74 Germany market estimates and forecast, 2018 - 2030
Fig. 75 France
Fig. 76 France market estimates and forecast, 2018 - 2030
Fig. 77 Italy
Fig. 78 Italy market estimates and forecast, 2018 - 2030
Fig. 79 Spain
Fig. 80 Spain market estimates and forecast, 2018 - 2030
Fig. 81 Denmark
Fig. 82 Denmark market estimates and forecast, 2018 - 2030
Fig. 83 Sweden
Fig. 84 Sweden market estimates and forecast, 2018 - 2030
Fig. 85 Norway
Fig. 86 Norway market estimates and forecast, 2018 - 2030
Fig. 87 Asia Pacific
Fig. 88 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 89 China
Fig. 90 China market estimates and forecast, 2018 - 2030
Fig. 91 Japan
Fig. 92 Japan market estimates and forecast, 2018 - 2030
Fig. 93 India
Fig. 94 India market estimates and forecast, 2018 - 2030
Fig. 95 Thailand
Fig. 96 Thailand. market estimates and forecast, 2018 - 2030
Fig. 97 South Korea
Fig. 98 South Korea market estimates and forecast, 2018 - 2030
Fig. 99 Australia
Fig. 100 Australia market estimates and forecast, 2018 - 2030
Fig. 101 Latin America
Fig. 102 Latin America market estimates and forecast, 2018 - 2030
Fig. 103 Brazil
Fig. 104 Brazil market estimates and forecast, 2018 - 2030
Fig. 105 Mexico
Fig. 106 Mexico market estimates and forecast, 2018 - 2030
Fig. 107 Argentina
Fig. 108 Argentina market estimates and forecast, 2018 - 2030
Fig. 109 Middle East and Africa
Fig. 110 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 111 South Africa
Fig. 112 South Africa market estimates and forecast, 2018 - 2030
Fig. 113 Saudi Arabia
Fig. 114 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 115 UAE
Fig. 116 UAE market estimates and forecast, 2018 - 2030
Fig. 117 Kuwait
Fig. 118 Kuwait market estimates and forecast, 2018 - 2030
Fig. 119 Participant categorization- drug delivery devices market
Fig. 120 Market share of key market players- drug delivery devices market
Companies Profiled
- Pfizer, Inc,
- F. Hoffmann-La Roche Ltd.
- Johnson and Johnson Services
- Novartis AG
- Bayer AG
- BD
- Uniqure N.V.
- SiBiono GeneTech Co.
- Shanghai Sunway Biotech Co., Ltd
- Human Stem Cells Institute
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 140 |
| Published | November 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 270.6 Billion |
| Forecasted Market Value ( USD | $ 403.6 Billion |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
